BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11174836)

  • 1. Counterregulatory responses to hypoglycemia in patients with maturity-onset diabetes of the young caused by HNF-1alpha gene mutations (MODY3).
    Guenat E; Seematter G; Philippe J; Temler E; Jéquier E; Tappy L
    Eur J Endocrinol; 2001 Jan; 144(1):45-9. PubMed ID: 11174836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene.
    Surmely JF; Guenat E; Philippe J; Dussoix P; Schneiter P; Temler E; Vaxillaire M; Froguel P; Jéquier E; Tappy L
    Diabetes; 1998 Sep; 47(9):1459-63. PubMed ID: 9726235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation.
    Hansen T; Eiberg H; Rouard M; Vaxillaire M; Møller AM; Rasmussen SK; Fridberg M; Urhammer SA; Holst JJ; Almind K; Echwald SM; Hansen L; Bell GI; Pedersen O
    Diabetes; 1997 Apr; 46(4):726-30. PubMed ID: 9075819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.
    Richter S; Shih DQ; Pearson ER; Wolfrum C; Fajans SS; Hattersley AT; Stoffel M
    Diabetes; 2003 Dec; 52(12):2989-95. PubMed ID: 14633861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin secretion and insulin sensitivity in diabetic and non-diabetic subjects with hepatic nuclear factor-1alpha (maturity-onset diabetes of the young-3) mutations.
    Vaxillaire M; Pueyo ME; Clément K; Fiet J; Timsit J; Philippe J; Robert JJ; Tappy L; Froguel P; Velho G
    Eur J Endocrinol; 1999 Dec; 141(6):609-18. PubMed ID: 10601964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counterregulatory responses to hypoglycemia in patients with glucokinase gene mutations.
    Guenat E; Seematter G; Philippe J; Temler E; Jequier E; Tappy L
    Diabetes Metab; 2000 Nov; 26(5):377-84. PubMed ID: 11119017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families.
    Costa A; Bescós M; Velho G; Chêvre J; Vidal J; Sesmilo G; Bellanné-Chantelot C; Froguel P; Casamitjana R; Rivera-Fillat F; Gomis R; Conget I
    Eur J Endocrinol; 2000 Apr; 142(4):380-6. PubMed ID: 10754480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased glibenclamide uptake in hepatocytes of hepatocyte nuclear factor-1alpha-deficient mice: a mechanism for hypersensitivity to sulfonylurea therapy in patients with maturity-onset diabetes of the young, type 3 (MODY3).
    Boileau P; Wolfrum C; Shih DQ; Yang TA; Wolkoff AW; Stoffel M
    Diabetes; 2002 Dec; 51 Suppl 3():S343-8. PubMed ID: 12475773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte nuclear factor-1alpha modulates pancreatic beta-cell growth by regulating the expression of insulin-like growth factor-1 in INS-1 cells.
    Yang Q; Yamagata K; Fukui K; Cao Y; Nammo T; Iwahashi H; Wang H; Matsumura I; Hanafusa T; Bucala R; Wollheim CB; Miyagawa J; Matsuzawa Y
    Diabetes; 2002 Jun; 51(6):1785-92. PubMed ID: 12031966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3).
    Yamagata K; Oda N; Kaisaki PJ; Menzel S; Furuta H; Vaxillaire M; Southam L; Cox RD; Lathrop GM; Boriraj VV; Chen X; Cox NJ; Oda Y; Yano H; Le Beau MM; Yamada S; Nishigori H; Takeda J; Fajans SS; Hattersley AT; Iwasaki N; Hansen T; Pedersen O; Polonsky KS; Bell GI
    Nature; 1996 Dec; 384(6608):455-8. PubMed ID: 8945470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4.
    Kaisaki PJ; Menzel S; Lindner T; Oda N; Rjasanowski I; Sahm J; Meincke G; Schulze J; Schmechel H; Petzold C; Ledermann HM; Sachse G; Boriraj VV; Menzel R; Kerner W; Turner RC; Yamagata K; Bell GI
    Diabetes; 1997 Mar; 46(3):528-35. PubMed ID: 9032114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene.
    Menzel R; Kaisaki PJ; Rjasanowski I; Heinke P; Kerner W; Menzel S
    Diabet Med; 1998 Oct; 15(10):816-20. PubMed ID: 9796880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and functional characterization of a novel mutation of hepatocyte nuclear factor-1alpha gene in a Korean family with MODY3.
    Kim KA; Kang K; Chi YI; Chang I; Lee MK; Kim KW; Shoelson SE; Lee MS
    Diabetologia; 2003 May; 46(5):721-7. PubMed ID: 12712243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preserved insulin response to tolbutamide in hepatocyte nuclear factor-1alpha mutation carriers.
    Sagen JV; Pearson ER; Johansen A; Spyer G; Søvik O; Pedersen O; Njølstad PR; Hattersley AT; Hansen T
    Diabet Med; 2005 Apr; 22(4):406-9. PubMed ID: 15787664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1beta and -1alpha mutations.
    Brackenridge A; Pearson ER; Shojaee-Moradie F; Hattersley AT; Russell-Jones D; Umpleby AM
    Diabetes; 2006 Feb; 55(2):405-11. PubMed ID: 16443774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3).
    Vaxillaire M; Rouard M; Yamagata K; Oda N; Kaisaki PJ; Boriraj VV; Chevre JC; Boccio V; Cox RD; Lathrop GM; Dussoix P; Philippe J; Timsit J; Charpentier G; Velho G; Bell GI; Froguel P
    Hum Mol Genet; 1997 Apr; 6(4):583-6. PubMed ID: 9097962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice.
    Pontoglio M; Sreenan S; Roe M; Pugh W; Ostrega D; Doyen A; Pick AJ; Baldwin A; Velho G; Froguel P; Levisetti M; Bonner-Weir S; Bell GI; Yaniv M; Polonsky KS
    J Clin Invest; 1998 May; 101(10):2215-22. PubMed ID: 9593777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prevalent amino acid polymorphism at codon 98 in the hepatocyte nuclear factor-1alpha gene is associated with reduced serum C-peptide and insulin responses to an oral glucose challenge.
    Urhammer SA; Fridberg M; Hansen T; Rasmussen SK; Møller AM; Clausen JO; Pedersen O
    Diabetes; 1997 May; 46(5):912-6. PubMed ID: 9133564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant-negative suppression of HNF-1alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic beta-cell line.
    Wang H; Maechler P; Hagenfeldt KA; Wollheim CB
    EMBO J; 1998 Nov; 17(22):6701-13. PubMed ID: 9822613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.